2019
DOI: 10.1182/blood-2018-07-864538
|View full text |Cite
|
Sign up to set email alerts
|

Human neutrophils express low levels of FcγRIIIA, which plays a role in PMN activation

Abstract: We have identified a rare healthy FcγRIIIB (CD16B)-null donor completely lacking FCGR3B RNA and protein expression and dissected the role of the different neutrophil Fcγ receptors in the response to therapeutic anti-CD20 monoclonal antibodies. We observed that polymorphonuclear neutrophils (PMNs) from FcγRIIIB wild-type (WT) individuals or the null donor were more effectively activated by chronic lymphocytic leukemia (CLL) B-cell targets opsonized with glycoengineered anti-CD20 antibodies compared with fully c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
48
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 48 publications
(49 citation statements)
references
References 65 publications
(108 reference statements)
1
48
0
Order By: Relevance
“…The FcgRIIIb-specific 11.5 blocking antibody, actually enhanced FcgRI up-regulation, as did PI-PLC, a FcgRIIIb-specific shedding enzyme. Moreover, the 3G8 blocking antibody (36), which does not discriminate between the two FcgRIII isoforms, did not affect FcgRI up-regulation, supporting the concept of a decoy role for that receptor (10,37,38). Results leave the possibility of a role for FcgRIIIa.…”
Section: Discussionmentioning
confidence: 77%
See 1 more Smart Citation
“…The FcgRIIIb-specific 11.5 blocking antibody, actually enhanced FcgRI up-regulation, as did PI-PLC, a FcgRIIIb-specific shedding enzyme. Moreover, the 3G8 blocking antibody (36), which does not discriminate between the two FcgRIII isoforms, did not affect FcgRI up-regulation, supporting the concept of a decoy role for that receptor (10,37,38). Results leave the possibility of a role for FcgRIIIa.…”
Section: Discussionmentioning
confidence: 77%
“…FcgRIIa, with its integrated signaling Immunoreceptor Tyrosine-based Activation Motif (ITAM), is an essential mediator of destructive antibody-based inflammation in autoimmunity (5) and is necessary for neutrophil recruitment within glomerular capillaries following IgG deposition (8,9). Also, a relatively modest expression of FcgRIIIa (CD16a) on neutrophils was recently demonstrated (10). FcgRIIIa is a classic activating receptor, which, upon stimulation, associates with an ITAM-signaling system.…”
Section: Introductionmentioning
confidence: 99%
“…The FcγRIIIa is expressed on NK cells and professional phagocytes, particularly macrophages. It is only recently apparent that FcγRIIIa is expressed on neutrophils, albeit at low levels, but plays a role in their function 23. FcγRIIIb is unique to humans and unlike other FcγRs it is attached to cell membrane via a glycophosphatidyl anchor.…”
Section: Human Fcγr General Propertiesmentioning
confidence: 99%
“…Afucosyl versions of the tumor targeting mAbs such as anti‐HER2, anti‐EGFR and anti‐CD20 had greater antitumor effects and increased survival,68,88,89 which is a reflection of the greatly increased, and selective, FcγRIII binding. Compared with their unmodified counterparts, the afucosyl mAbs showed dramatic improvement of FcγRIII‐related effector responses such as stronger NK cell‐mediated ADCC, or enhanced neutrophil‐mediated phagocytosis through FcγRIIIb and/or FcγRIIIa 23. However, certain neutrophil functions via FcγRIIa may be compromised 90,91…”
Section: Igg Subclasses: Structure and Propertiesmentioning
confidence: 99%
“…FcγRIIIb is known to be very abundant on human neutrophils, while FcγRIIIa is not present 19,34 . However the absence of FcγRIIIa from neutrophils has recently been challenged 35 . The western blot showed a smear from 50 to 80 kDa when probed with an anti-CD16 antibody (Figure 1).…”
Section: Fcγriiib Purification and Identificationmentioning
confidence: 99%